Swiss neurogaming company MindMaze has received FDA clearance for its MindMotion Pro platform, a motion capture system similar to the Microsoft Kinect which can be used in rehabilitation of stroke and traumatic injury patients.
“In the last few years we’ve launched products at the intersection of the brain and VR,” MindMaze CEO Tej Tadi told MobiHealthNews. “What we’ve done today very specifically is talking about the MindMotion platform, which got FDA clearance. The MindMotion platform is really a hospital-based product. It’s a really early acute app usually meant to accelerate neural recovery for patients who have ended up with movement deficits.”